Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07359287

Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care

Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care: A Cluster-Randomized Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
4,500 (estimated)
Sponsor
University Hospital, Caen · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Antimicrobial resistance (AMR), considered one of the greatest global threats by the WHO, justifies the development of initiatives to promote appropriate antibiotic use-especially in primary care, where most antibiotics in France are prescribed and where misuse remains common. We are proposing a cluster-randomized controlled trial to evaluate the effectiveness of a bimodal intervention combining: (1) improved communication about the circulation of respiratory viruses, and (2) strengthened collaborative practices between general practitioners and pharmacists through a multidisciplinary protocol aimed at verifying that prescribed treatment durations comply with guidelines. The study will include six primary care practices (24 physicians), with three practices in each study arm. The aim of this project is to assess whether the bimodal intervention can reduce the duration of antibiotic treatments for upper and lower respiratory tract infections. The first component (a "viral infection prescription" tool) focuses on reducing unnecessary treatment initiation, while the second (pharmacist-led review) aims to shorten excessive prescription durations.

Conditions

Interventions

TypeNameDescription
OTHERAntibiotic prescribing according to guidelinesIf necessary, the general practitioner prescribes antibiotics to patients consulting for an upper or lower respiratory tract infection, according to the guidelines.

Timeline

Start date
2025-12-01
Primary completion
2026-06-01
Completion
2026-09-01
First posted
2026-01-22
Last updated
2026-01-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07359287. Inclusion in this directory is not an endorsement.